Clinical trial
A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Subepithelial Implantation of the Transform Corneal Allograft (TCA) for Improving Near Vision in Presbyopic Subjects
NCT03675438 is registered in ClinicalTrials.gov with Allotex, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Subepithelial Implantation of the Transform Corneal Allograft (TCA) for Improving Near Vision in Presbyopic Subjects
- Lead sponsor
- Allotex, Inc.
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- October 31, 2018
- Completion date
- January 31, 2021
- Enrollment
- 0 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.